KATIE BREWSTER OSTEOPATH LIMITEDActive

Company number 08037009Private limited companyIncorporated 2012

Key figures

£13,404-2.9%
Net assets 2024/25
-17.9%
Average annual change 2020/21–2024/25
010 k20 k30 k2020/212021/222022/232023/242024/25

Like most small UK companies, KATIE BREWSTER OSTEOPATH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k60 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand53,058————
Total assets56,72658,04641,88826,43328,820
Total liabilities—30,36418,32110,24212,863
Net assets / total equity29,47725,73521,41213,80213,404
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

86220

As described in the company's latest filed accounts.

Summary: KATIE BREWSTER OSTEOPATH LIMITED

Company

KATIE BREWSTER OSTEOPATH LIMITED is a private limited company registered with Companies House under company number 08037009. It was incorporated on 19 Apr 2012. Its status is active. The registered office is in Settle (BD24). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files micro-entity accounts. Net assets were £13,404, down 2.9% on the previous year. Total assets were £28,820 and total liabilities £12,863. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 3 May 2027.